Evaluating blood–brain barrier permeability in a rat model of type 2 diabetes

Journal of Translational Medicine

Craig F. Ferris¹  Christopher M. Lawson¹  Kilian F. G. Rentrup¹  Ju Qiao¹  Praveen Kulkarni¹ 

[1] Center for Translational NeuroImaging, Northeastern University;

关键词: Quantitative ultrashort time-to-echo;    Contrast enhanced (QUTE-CE);    Magnetic resonance imaging;    Small vessel disease;    BBZDR/Wor rat;    Diabetic encephalopathy;   

DOI  :  10.1186/s12967-020-02428-3

来源: DOAJ

【 摘 要 】

Abstract Background This is an exploratory study using a novel imaging modality, quantitative ultrashort time-to-echo, contrast enhanced (QUTE-CE) magnetic resonance imaging to evaluate the permeability of the blood–brain barrier in a rat model of type 2 diabetes with the presumption that small vessel disease is a contributing factor to neuropathology in diabetes. Methods The BBZDR/Wor rat, a model of type 2 diabetes, and age-matched controls were studied for changes in blood–brain barrier permeability. QUTE-CE, a quantitative vascular biomarker, generated angiographic images with over 500,000 voxels that were registered to a 3D MRI rat brain atlas providing site-specific information on blood–brain barrier permeability in 173 different brain areas. Results In this model of diabetes, without the support of insulin treatment, there was global capillary pathology with over 84% of the brain showing a significant increase in blood–brain barrier permeability over wild-type controls. Areas of the cerebellum and midbrain dopaminergic system were not significantly affected. Conclusion Small vessel disease as assessed by permeability in the blood–brain barrier in type 2 diabetes is pervasive and includes much of the brain. The increase in blood–brain barrier permeability is a likely contributing factor to diabetic encephalopathy and dementia.

【 授权许可】

Unknown